Loading company
Estrella Immunopharma, Inc.
ESLA · Nasdaq · ·
$0.46-0.2%Sep 29 close
- 1M
- -34.7%
- 6M
- -55.3%
- 1Y
- -60.0%
- 5Y
- -95.3%
ESLA · Nasdaq · ·
$0.46-0.2%Sep 29 close
The quarter ending June 30, 2026, against the same quarter a year earlier.
| Measure | 3 months toJun 30, 2026 | 3 months toJun 30, 2025 | Change |
|---|---|---|---|
| Profit | -$2.3M | -$5.5M | +58.41% |
| Profit per share | -$0.05 | -$0.15 | +66.67% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
Estrella Immunopharma, Inc. has no earnings call transcript available.